InsidersTradesSigma
TAH Stock: price and directors' dealings · New Zealand · NZX
Follow the TAH share price and the full management transaction log of the company, a listed equity based in New Zealand. Shares trade on NZ NZ, under the supervision of NZX. Operating in the Health Care sector, TAH has logged 6 public disclosures. Market capitalisation: €45.8m. The latest transaction was reported on 8 July 2026 (Other). Among the most active insiders: TAH Insider. All data is free.
6
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
8Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,013 of 25,724 companies
75.9
score / 100
Value72
Quality80
FCF yld8.4%
Earn yld6.2%
EV/EBITDA8.8x
ROE65%
Gross mgn50%
Net mgn13%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 July 2026
Declarations6 total
ShareASXASX:2924-03102001-3A695647
ShareASXASX:2924-03101189-3A695488
Ordinary ShareNZX Main BoardNZX:472685
ShareASXASX:2924-03081398-3A691815
6 of 6 declarations
About TAH
TAH is a company operating in the healthcare and pharmaceutical sector. It is listed on the XNZE market.